PCRX — Pacira BioSciences, Inc. · P/E 174, rev $369.8M

Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.

Use this PCRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PCRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PCRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Pacira BioSciences, Inc. even when a live quote feed is slow.